# CV Sciences Plans +PlusHLTH Launches Over 12 to 24 Months as Q3 Gross Margin Hits 50%

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/56095
Published: 2026-11-13T00:20:36.000Z
Updated: 2026-11-13T00:20:36.000Z
Section: Business

> The company reported positive adjusted EBITDA and about $64,000 in operating cash flow for the quarter.

CV Sciences, Inc. plans several non-cannabinoid launches under its +PlusHLTH brand over the next 12 to 24 months, aiming to support organic growth and offset regulation-related revenue pressure.

The company recorded a 50% gross margin in the third quarter of 2026. Operating cash flow was about $64,000, and adjusted EBITDA was positive.

CEO, Secretary and Director Joseph Dowling said sales, gross margin, operating performance and adjusted EBITDA all increased sequentially. “This quarter, we increased sales, gross margin, operating performance, and adjusted EBITDA on a sequential basis,” Dowling said.